Search Results - "Iadeluca, L"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    The burden of family caregiving in the United States: work productivity, health care resource utilization, and mental health among employed adults by Hopps, Markay, Iadeluca, Laura, McDonald, Margaret, Makinson, Geoffrey T

    Published in Journal of multidisciplinary healthcare (01-01-2017)
    “…Family caregiving is an increasingly important component of care for patients and the elderly. The aim of this study is to characterize the burden of family…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Maternal Screening And Treatment For Group B Streptococcus (GBS) Are Associated With Non-Adherence To Guidelines, False-Negative Results And High Management Costs In The United Kingdom, Italy, France, Spain And Germany by Iadeluca, L, Farrington, E, McLean, T, Rousseau, B, Agosti, Y, Absalon, J, Anderson, AS

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: Group B streptococcus (GBS) rectovaginal carriage during late pregnancy and birth is associated with neonatal GBS disease which is life threatening…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Nuclear medicine in primary bone tumors by Focacci, Carlo, Lattanzi, Rossella, Iadeluca, Maria Laura, Campioni, Paolo

    Published in European journal of radiology (01-05-1998)
    “…Introduction: Conventional radiography is the method of choice to diagnose a primary bone tumor but in many cases it is necessary to integrate it with nuclear…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    The burden of selected cancers in the US: health behaviors and health care resource utilization by Iadeluca, Laura, Mardekian, Jack, Chander, Pratibha, Hopps, Markay, Makinson, Geoffrey T

    Published in Cancer management and research (01-01-2017)
    “…To characterize the disease burden among survivors of those cancers having the highest incidence in the US. Adult (≥18 years) survivors of the 11 most…”
    Get full text
    Journal Article
  16. 16

    PARPi monotherapy as first-line maintenance following chemotherapy + bevacizumab in advanced ovarian cancer by Kudrik, Fred J., Vasudevan, Anupama, English, Sandy, Gart, Mike, Oladipo, Taofikat, Hartman, John, Iadeluca, Laura L.

    Published in Journal of clinical oncology (01-06-2023)
    “…e17601 Background: Chemotherapy (CT) + bevacizumab is a standard-of-care option for first-line (1L) treatment for patients with advanced ovarian cancer (AOC)…”
    Get full text
    Journal Article
  17. 17

    Real-world outcomes of first-line maintenance with niraparib or bevacizumab in advanced ovarian cancer by Vasudevan, Anupama, English, Sandy, Gart, Mike, Oladipo, Taofikat, Hartman, John, Iadeluca, Laura L., Kudrik, Fred J.

    Published in Journal of clinical oncology (01-06-2023)
    “…e17598 Background: Niraparib and bevacizumab are the only FDA-approved first-line maintenance (1LM) therapies for advanced ovarian cancer (AOC) without a…”
    Get full text
    Journal Article